| scholarly article | Q13442814 |
| P50 | author | Yann-Gaël Gangloff | Q56452314 |
| E Goillot | Q70150428 | ||
| Agnès Duplany | Q82038373 | ||
| Laetitia Mazelin | Q84891671 | ||
| P2093 | author name string | Qing Zhang | |
| Jie Chen | |||
| Laurent Schaeffer | |||
| Nathalie Streichenberger | |||
| Shuzhe Ding | |||
| Karine Gauthier | |||
| Vincent Moncollin | |||
| Sandrine Mouradian | |||
| Céline Angleraux | |||
| P2860 | cites work | siRNA-based gene silencing reveals specialized roles of IRS-1/Akt2 and IRS-2/Akt1 in glucose and lipid metabolism in human skeletal muscle | Q24295160 |
| mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery | Q24302549 | ||
| Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive | Q24306328 | ||
| Insulin and insulin resistance. | Q24532776 | ||
| Myopathy caused by mammalian target of rapamycin complex 1 (mTORC1) inactivation is not reversed by restoring mitochondrial function | Q24614867 | ||
| Skeletal muscle protein balance in mTOR heterozygous mice in response to inflammation and leucine | Q24633679 | ||
| Skeletal Muscle Regulates Metabolism via Interorgan Crosstalk: Roles in Health and Disease | Q26744260 | ||
| Cellular and molecular mechanisms of muscle atrophy | Q27012762 | ||
| Stressed Liver and Muscle Call on Adipocytes with FGF21 | Q27014973 | ||
| A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells | Q28141706 | ||
| Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo | Q28206290 | ||
| Phosphorylation of mammalian target of rapamycin (mTOR) at Ser-2448 is mediated by p70S6 kinase | Q28251385 | ||
| Identification of S6 kinase 1 as a novel mammalian target of rapamycin (mTOR)-phosphorylating kinase | Q28251762 | ||
| Increased mammalian lifespan and a segmental and tissue-specific slowing of aging after genetic reduction of mTOR expression | Q28297737 | ||
| Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB | Q28306356 | ||
| AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1 | Q28506431 | ||
| A protein kinase B-dependent and rapamycin-sensitive pathway controls skeletal muscle growth but not fiber type specification | Q28574258 | ||
| FoxO3 controls autophagy in skeletal muscle in vivo | Q29614483 | ||
| mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complex | Q29617214 | ||
| Muscle-specific deletion of rictor impairs insulin-stimulated glucose transport and enhances Basal glycogen synthase activity | Q30442556 | ||
| Serine/threonine phosphorylation of IRS-1 triggers its degradation: possible regulation by tyrosine phosphorylation | Q31809728 | ||
| A kinase-dead knock-in mutation in mTOR leads to early embryonic lethality and is dispensable for the immune system in heterozygous mice | Q33449060 | ||
| Dynamics of muscle fibre growth during postnatal mouse development | Q33533474 | ||
| Muscle inactivation of mTOR causes metabolic and dystrophin defects leading to severe myopathy | Q33589972 | ||
| Regulation of glucose transporter 4 translocation by the Rab guanosine triphosphatase-activating protein AS160/TBC1D4: role of phosphorylation and membrane association | Q33642606 | ||
| Metabolic role of fibroblast growth factor 21 in liver, adipose and nervous system tissues | Q33685319 | ||
| Age-Associated Loss of OPA1 in Muscle Impacts Muscle Mass, Metabolic Homeostasis, Systemic Inflammation, and Epithelial Senescence. | Q33773474 | ||
| Satellite cells and the muscle stem cell niche | Q33816665 | ||
| Loss of mTORC1 signalling impairs β-cell homeostasis and insulin processing | Q33903835 | ||
| Hepatic mTORC1 controls locomotor activity, body temperature, and lipid metabolism through FGF21. | Q34060841 | ||
| Myogenic satellite cells: physiology to molecular biology | Q34084128 | ||
| Insulin-stimulated phosphorylation of a Rab GTPase-activating protein regulates GLUT4 translocation | Q34183649 | ||
| Protein kinase B (PKB/Akt)--a key regulator of glucose transport? | Q34189344 | ||
| Sustained activation of mTORC1 in skeletal muscle inhibits constitutive and starvation-induced autophagy and causes a severe, late-onset myopathy | Q34340407 | ||
| Knock-in mice for the R50X mutation in the PYGM gene present with McArdle disease. | Q34639597 | ||
| Emerging role for AS160/TBC1D4 and TBC1D1 in the regulation of GLUT4 traffic | Q34778453 | ||
| Skeletal muscle-specific ablation of raptor, but not of rictor, causes metabolic changes and results in muscle dystrophy | Q34891582 | ||
| Raptor and Rheb negatively regulate skeletal myogenesis through suppression of insulin receptor substrate 1 (IRS1). | Q35371402 | ||
| Perilipin 5-Driven Lipid Droplet Accumulation in Skeletal Muscle Stimulates the Expression of Fibroblast Growth Factor 21 | Q35881713 | ||
| A unifying model for mTORC1-mediated regulation of mRNA translation. | Q35945036 | ||
| Muscle-specific 4E-BP1 signaling activation improves metabolic parameters during aging and obesity | Q36040443 | ||
| Defective mitochondrial morphology and bioenergetic function in mice lacking the transcription factor Yin Yang 1 in skeletal muscle | Q36211023 | ||
| Intact satellite cells lead to remarkable protection against Smn gene defect in differentiated skeletal muscle. | Q36323505 | ||
| Deletion of murine SMN exon 7 directed to skeletal muscle leads to severe muscular dystrophy | Q36379979 | ||
| Mammalian target of rapamycin (mTOR) signaling network in skeletal myogenesis | Q36481912 | ||
| Nutrient overload, insulin resistance, and ribosomal protein S6 kinase 1, S6K1. | Q36497296 | ||
| Whole body and skeletal muscle protein turnover in recovery from burns. | Q36576536 | ||
| The underappreciated role of muscle in health and disease | Q36588837 | ||
| TNF-α-Induced microRNAs Control Dystrophin Expression in Becker Muscular Dystrophy | Q36590389 | ||
| Cardiac restricted overexpression of kinase-dead mammalian target of rapamycin (mTOR) mutant impairs the mTOR-mediated signaling and cardiac function | Q36646353 | ||
| mTOR signaling and the molecular adaptation to resistance exercise. | Q36649624 | ||
| Alterations to mTORC1 signaling in the skeletal muscle differentially affect whole-body metabolism | Q36709204 | ||
| Differential response of skeletal muscles to mTORC1 signaling during atrophy and hypertrophy. | Q36755594 | ||
| Impaired Mitochondrial Fat Oxidation Induces FGF21 in Muscle | Q36936246 | ||
| FGF21 is an Akt-regulated myokine | Q37017459 | ||
| Abnormal growth in mitochondrial disease | Q37361327 | ||
| mTOR regulates skeletal muscle regeneration in vivo through kinase-dependent and kinase-independent mechanisms | Q37474514 | ||
| Conditional activation of akt in adult skeletal muscle induces rapid hypertrophy | Q37574344 | ||
| FGF21 is a biomarker for mitochondrial translation and mtDNA maintenance disorders | Q37610032 | ||
| Mechanisms regulating skeletal muscle growth and atrophy | Q38091731 | ||
| mTOR signaling in cellular and organismal energetics | Q38305897 | ||
| mTOR: a pharmacologic target for autophagy regulation | Q38345168 | ||
| Skeletal muscle mitochondrial uncoupling drives endocrine cross-talk through the induction of FGF21 as a myokine | Q39042458 | ||
| Metformin-induced inhibition of the mitochondrial respiratory chain increases FGF21 expression via ATF4 activation | Q39095069 | ||
| Considerations on mTOR regulation at serine 2448: implications for muscle metabolism studies. | Q39144817 | ||
| Fast/Glycolytic muscle fiber growth reduces fat mass and improves metabolic parameters in obese mice | Q39280475 | ||
| Atrophy of S6K1(-/-) skeletal muscle cells reveals distinct mTOR effectors for cell cycle and size control. | Q40456155 | ||
| Increased AKT S473 phosphorylation after mTORC1 inhibition is rictor dependent and does not predict tumor cell response to PI3K/mTOR inhibition | Q42452282 | ||
| mTOR complex 2 regulates proper turnover of insulin receptor substrate-1 via the ubiquitin ligase subunit Fbw8. | Q42500373 | ||
| Mammalian target of rapamycin is a direct target for protein kinase B: identification of a convergence point for opposing effects of insulin and amino-acid deficiency on protein translation. | Q42995176 | ||
| GLUT4 vesicle recruitment and fusion are differentially regulated by Rac, AS160, and Rab8A in muscle cells | Q46466470 | ||
| Differential glucose metabolism in mice and humans affected by McArdle disease. | Q46535269 | ||
| Differential Muscle Involvement in Mice and Humans Affected by McArdle Disease. | Q46571361 | ||
| A potential link between muscle peroxisome proliferator- activated receptor-alpha signaling and obesity-related diabetes | Q46626385 | ||
| Ethical guidelines for publishing in the journal of cachexia, sarcopenia and muscle: update 2017. | Q47664420 | ||
| mTORC1 Regulates Mitochondrial Integrated Stress Response and Mitochondrial Myopathy Progression. | Q47999496 | ||
| Overexpression of Kinase-Dead mTOR Impairs Glucose Homeostasis by Regulating Insulin Secretion and Not β-Cell Mass. | Q48090067 | ||
| Canonical signaling and nuclear activity of mTOR-a teamwork effort to regulate metabolism and cell growth | Q50029516 | ||
| mTORC1 Balances Cellular Amino Acid Supply with Demand for Protein Synthesis through Post-transcriptional Control of ATF4. | Q50142087 | ||
| mTORC1 Is a Major Regulatory Node in the FGF21 Signaling Network in Adipocytes. | Q50578906 | ||
| mTOR inactivation in myocardium from infant mice rapidly leads to dilated cardiomyopathy due to translation defects and p53/JNK-mediated apoptosis. | Q53110486 | ||
| Activation of mTORC1 in skeletal muscle regulates whole-body metabolism through FGF21. | Q53438320 | ||
| mTOR Signaling in Growth, Metabolism, and Disease. | Q54144950 | ||
| mTORC1 controls mitochondrial activity and biogenesis through 4E-BP-dependent translational regulation. | Q54398394 | ||
| Peroxisome proliferator-activated receptor delta controls muscle development and oxidative capability | Q57600775 | ||
| Increased Serpina3n release into circulation during glucocorticoid-mediated muscle atrophy. | Q64881548 | ||
| Age-related differences in absolute numbers of skeletal muscle satellite cells | Q71111509 | ||
| Functional studies of Akt isoform specificity in skeletal muscle in vivo; maintained insulin sensitivity despite reduced insulin receptor substrate-1 expression | Q79188519 | ||
| Skeletal muscle fiber-type switching, exercise intolerance, and myopathy in PGC-1alpha muscle-specific knock-out animals | Q80804178 | ||
| The role of skeletal muscle mTOR in the regulation of mechanical load-induced growth | Q84984851 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 1 | |
| P304 | page(s) | 35-53 | |
| P577 | publication date | 2018-11-21 | |
| P1433 | published in | Journal of Cachexia, Sarcopenia and Muscle | Q6294897 |
| P1476 | title | Lack of muscle mTOR kinase activity causes early onset myopathy and compromises whole-body homeostasis | |
| P478 | volume | 10 |
| Q92816070 | Suppression of AMD-Like Pathology by Mitochondria-Targeted Antioxidant SkQ1 Is Associated with a Decrease in the Accumulation of Amyloid β and in mTOR Activity | cites work | P2860 |
Search more.